img

Global Valsartan Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Valsartan Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
Valsartan Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Valsartan Drug market is projected to reach US$ 866.2 million in 2029, increasing from US$ 589 million in 2022, with the CAGR of 6.4% during the period of 2024 to 2029. Demand from Hypertension and Heart Failure are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Valsartan Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets

Segment by Application


Hypertension
Heart Failure
Heart Attack

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Valsartan Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Valsartan Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Valsartan Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Valsartan Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Valsartan Drug introduction, etc. Valsartan Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Valsartan Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Valsartan Drug Market Overview
1.1 Valsartan Drug Product Overview
1.2 Valsartan Drug Market Segment by Type
1.2.1 40 mg Tablets
1.2.2 80 mg Tablets
1.2.3 160 mg Tablets
1.2.4 320 mg Tablets
1.3 Global Valsartan Drug Market Size by Type
1.3.1 Global Valsartan Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Valsartan Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Valsartan Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Valsartan Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Valsartan Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Valsartan Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Valsartan Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Valsartan Drug Sales Breakdown by Type (2018-2024)
2 Global Valsartan Drug Market Competition by Company
2.1 Global Top Players by Valsartan Drug Sales (2018-2024)
2.2 Global Top Players by Valsartan Drug Revenue (2018-2024)
2.3 Global Top Players by Valsartan Drug Price (2018-2024)
2.4 Global Top Manufacturers Valsartan Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Valsartan Drug Market Competitive Situation and Trends
2.5.1 Valsartan Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Valsartan Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valsartan Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Valsartan Drug Market
2.8 Key Manufacturers Valsartan Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Valsartan Drug Status and Outlook by Region
3.1 Global Valsartan Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Valsartan Drug Historic Market Size by Region
3.2.1 Global Valsartan Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Valsartan Drug Sales in Value by Region (2018-2024)
3.2.3 Global Valsartan Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Valsartan Drug Forecasted Market Size by Region
3.3.1 Global Valsartan Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Valsartan Drug Sales in Value by Region (2024-2029)
3.3.3 Global Valsartan Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Valsartan Drug by Application
4.1 Valsartan Drug Market Segment by Application
4.1.1 Hypertension
4.1.2 Heart Failure
4.1.3 Heart Attack
4.2 Global Valsartan Drug Market Size by Application
4.2.1 Global Valsartan Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Valsartan Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Valsartan Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Valsartan Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Valsartan Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Valsartan Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Valsartan Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Valsartan Drug Sales Breakdown by Application (2018-2024)
5 North America Valsartan Drug by Country
5.1 North America Valsartan Drug Historic Market Size by Country
5.1.1 North America Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Valsartan Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Valsartan Drug Sales in Value by Country (2018-2024)
5.2 North America Valsartan Drug Forecasted Market Size by Country
5.2.1 North America Valsartan Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Valsartan Drug Sales in Value by Country (2024-2029)
6 Europe Valsartan Drug by Country
6.1 Europe Valsartan Drug Historic Market Size by Country
6.1.1 Europe Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Valsartan Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Valsartan Drug Sales in Value by Country (2018-2024)
6.2 Europe Valsartan Drug Forecasted Market Size by Country
6.2.1 Europe Valsartan Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Valsartan Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Valsartan Drug by Region
7.1 Asia-Pacific Valsartan Drug Historic Market Size by Region
7.1.1 Asia-Pacific Valsartan Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Valsartan Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Valsartan Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Valsartan Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Valsartan Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Valsartan Drug Sales in Value by Region (2024-2029)
8 Latin America Valsartan Drug by Country
8.1 Latin America Valsartan Drug Historic Market Size by Country
8.1.1 Latin America Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Valsartan Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Valsartan Drug Sales in Value by Country (2018-2024)
8.2 Latin America Valsartan Drug Forecasted Market Size by Country
8.2.1 Latin America Valsartan Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Valsartan Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Valsartan Drug by Country
9.1 Middle East and Africa Valsartan Drug Historic Market Size by Country
9.1.1 Middle East and Africa Valsartan Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Valsartan Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Valsartan Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Valsartan Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Valsartan Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Valsartan Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Valsartan Drug Products Offered
10.1.5 Novartis Recent Development
10.2 Sun Pharmaceutical
10.2.1 Sun Pharmaceutical Company Information
10.2.2 Sun Pharmaceutical Introduction and Business Overview
10.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sun Pharmaceutical Valsartan Drug Products Offered
10.2.5 Sun Pharmaceutical Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Teva Valsartan Drug Products Offered
10.3.5 Teva Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Mylan Valsartan Drug Products Offered
10.4.5 Mylan Recent Development
10.5 Alembic Pharmaceuticals
10.5.1 Alembic Pharmaceuticals Company Information
10.5.2 Alembic Pharmaceuticals Introduction and Business Overview
10.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Alembic Pharmaceuticals Valsartan Drug Products Offered
10.5.5 Alembic Pharmaceuticals Recent Development
10.6 Lupin
10.6.1 Lupin Company Information
10.6.2 Lupin Introduction and Business Overview
10.6.3 Lupin Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Lupin Valsartan Drug Products Offered
10.6.5 Lupin Recent Development
10.7 Aurobindo Pharma
10.7.1 Aurobindo Pharma Company Information
10.7.2 Aurobindo Pharma Introduction and Business Overview
10.7.3 Aurobindo Pharma Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Aurobindo Pharma Valsartan Drug Products Offered
10.7.5 Aurobindo Pharma Recent Development
10.8 Macleods Pharmaceuticals
10.8.1 Macleods Pharmaceuticals Company Information
10.8.2 Macleods Pharmaceuticals Introduction and Business Overview
10.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Macleods Pharmaceuticals Valsartan Drug Products Offered
10.8.5 Macleods Pharmaceuticals Recent Development
10.9 HETERO
10.9.1 HETERO Company Information
10.9.2 HETERO Introduction and Business Overview
10.9.3 HETERO Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 HETERO Valsartan Drug Products Offered
10.9.5 HETERO Recent Development
10.10 Torrent Pharmaceuticals
10.10.1 Torrent Pharmaceuticals Company Information
10.10.2 Torrent Pharmaceuticals Introduction and Business Overview
10.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Torrent Pharmaceuticals Valsartan Drug Products Offered
10.10.5 Torrent Pharmaceuticals Recent Development
10.11 Huaren Pharmaceutical
10.11.1 Huaren Pharmaceutical Company Information
10.11.2 Huaren Pharmaceutical Introduction and Business Overview
10.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Huaren Pharmaceutical Valsartan Drug Products Offered
10.11.5 Huaren Pharmaceutical Recent Development
10.12 Jubilant Pharma
10.12.1 Jubilant Pharma Company Information
10.12.2 Jubilant Pharma Introduction and Business Overview
10.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Jubilant Pharma Valsartan Drug Products Offered
10.12.5 Jubilant Pharma Recent Development
10.13 Amneal Pharmaceuticals
10.13.1 Amneal Pharmaceuticals Company Information
10.13.2 Amneal Pharmaceuticals Introduction and Business Overview
10.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Amneal Pharmaceuticals Valsartan Drug Products Offered
10.13.5 Amneal Pharmaceuticals Recent Development
10.14 Zhejiang Huahai Pharmaceutical
10.14.1 Zhejiang Huahai Pharmaceutical Company Information
10.14.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview
10.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Products Offered
10.14.5 Zhejiang Huahai Pharmaceutical Recent Development
10.15 Square Pharmaceuticals
10.15.1 Square Pharmaceuticals Company Information
10.15.2 Square Pharmaceuticals Introduction and Business Overview
10.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Square Pharmaceuticals Valsartan Drug Products Offered
10.15.5 Square Pharmaceuticals Recent Development
10.16 Unichem Laboratories
10.16.1 Unichem Laboratories Company Information
10.16.2 Unichem Laboratories Introduction and Business Overview
10.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Unichem Laboratories Valsartan Drug Products Offered
10.16.5 Unichem Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Valsartan Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Valsartan Drug Industrial Chain Analysis
11.4 Valsartan Drug Market Dynamics
11.4.1 Valsartan Drug Industry Trends
11.4.2 Valsartan Drug Market Drivers
11.4.3 Valsartan Drug Market Challenges
11.4.4 Valsartan Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Valsartan Drug Distributors
12.3 Valsartan Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 40 mg Tablets
Table 2. Major Company of 80 mg Tablets
Table 3. Major Company of 160 mg Tablets
Table 4. Major Company of 320 mg Tablets
Table 5. Global Valsartan Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Valsartan Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Valsartan Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Valsartan Drug Market Share in Value by Type (2018-2024)
Table 10. Global Valsartan Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 12. Global Valsartan Drug Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Valsartan Drug Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Valsartan Drug Sales Market Share in Value by Type (2024-2029)
Table 15. Global Valsartan Drug Price by Type (2024-2029) & (USD/Unit)
Table 16. North America Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Valsartan Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Valsartan Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Valsartan Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Valsartan Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Valsartan Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Valsartan Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Valsartan Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Valsartan Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Valsartan Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Valsartan Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Valsartan Drug Sales Share by Company (2018-2024)
Table 28. Global Valsartan Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Valsartan Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Valsartan Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Valsartan Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Valsartan Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valsartan Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Valsartan Drug Market
Table 35. Key Manufacturers Valsartan Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Valsartan Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Valsartan Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Valsartan Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Valsartan Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Valsartan Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Valsartan Drug Sales by Region (2024-2029) & (K Units)
Table 44. Global Valsartan Drug Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Valsartan Drug Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Valsartan Drug Sales Market Share in Value by Region (2024-2029)
Table 47. Global Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 48. Global Valsartan Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Valsartan Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Valsartan Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Valsartan Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Valsartan Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 55. Global Valsartan Drug Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Valsartan Drug Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Valsartan Drug Sales Market Share in Value by Application (2024-2029)
Table 58. Global Valsartan Drug Price by Application (2024-2029) & (USD/Unit)
Table 59. North America Valsartan Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Valsartan Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Valsartan Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Valsartan Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Valsartan Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Valsartan Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Valsartan Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Valsartan Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Valsartan Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Valsartan Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Valsartan Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Valsartan Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Valsartan Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 74. North America Valsartan Drug Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Valsartan Drug Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Valsartan Drug Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Valsartan Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Valsartan Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Valsartan Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 82. Europe Valsartan Drug Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Valsartan Drug Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Valsartan Drug Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Valsartan Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Valsartan Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Valsartan Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Valsartan Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Valsartan Drug Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Valsartan Drug Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Valsartan Drug Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Valsartan Drug Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Valsartan Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Valsartan Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Valsartan Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Valsartan Drug Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Valsartan Drug Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Valsartan Drug Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Valsartan Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Valsartan Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Valsartan Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Valsartan Drug Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Valsartan Drug Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Valsartan Drug Sales Market Share in Value by Country (2024-2029)
Table 109. Novartis Company Information
Table 110. Novartis Introduction and Business Overview
Table 111. Novartis Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Valsartan Drug Product
Table 113. Novartis Recent Development
Table 114. Sun Pharmaceutical Company Information
Table 115. Sun Pharmaceutical Introduction and Business Overview
Table 116. Sun Pharmaceutical Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sun Pharmaceutical Valsartan Drug Product
Table 118. Sun Pharmaceutical Recent Development
Table 119. Teva Company Information
Table 120. Teva Introduction and Business Overview
Table 121. Teva Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Teva Valsartan Drug Product
Table 123. Teva Recent Development
Table 124. Mylan Company Information
Table 125. Mylan Introduction and Business Overview
Table 126. Mylan Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Mylan Valsartan Drug Product
Table 128. Mylan Recent Development
Table 129. Alembic Pharmaceuticals Company Information
Table 130. Alembic Pharmaceuticals Introduction and Business Overview
Table 131. Alembic Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Alembic Pharmaceuticals Valsartan Drug Product
Table 133. Alembic Pharmaceuticals Recent Development
Table 134. Lupin Company Information
Table 135. Lupin Introduction and Business Overview
Table 136. Lupin Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Lupin Valsartan Drug Product
Table 138. Lupin Recent Development
Table 139. Aurobindo Pharma Company Information
Table 140. Aurobindo Pharma Introduction and Business Overview
Table 141. Aurobindo Pharma Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Aurobindo Pharma Valsartan Drug Product
Table 143. Aurobindo Pharma Recent Development
Table 144. Macleods Pharmaceuticals Company Information
Table 145. Macleods Pharmaceuticals Introduction and Business Overview
Table 146. Macleods Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Macleods Pharmaceuticals Valsartan Drug Product
Table 148. Macleods Pharmaceuticals Recent Development
Table 149. HETERO Company Information
Table 150. HETERO Introduction and Business Overview
Table 151. HETERO Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. HETERO Valsartan Drug Product
Table 153. HETERO Recent Development
Table 154. Torrent Pharmaceuticals Company Information
Table 155. Torrent Pharmaceuticals Introduction and Business Overview
Table 156. Torrent Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Torrent Pharmaceuticals Valsartan Drug Product
Table 158. Torrent Pharmaceuticals Recent Development
Table 159. Huaren Pharmaceutical Company Information
Table 160. Huaren Pharmaceutical Introduction and Business Overview
Table 161. Huaren Pharmaceutical Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Huaren Pharmaceutical Valsartan Drug Product
Table 163. Huaren Pharmaceutical Recent Development
Table 164. Jubilant Pharma Company Information
Table 165. Jubilant Pharma Introduction and Business Overview
Table 166. Jubilant Pharma Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Jubilant Pharma Valsartan Drug Product
Table 168. Jubilant Pharma Recent Development
Table 169. Amneal Pharmaceuticals Company Information
Table 170. Amneal Pharmaceuticals Introduction and Business Overview
Table 171. Amneal Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Amneal Pharmaceuticals Valsartan Drug Product
Table 173. Amneal Pharmaceuticals Recent Development
Table 174. Zhejiang Huahai Pharmaceutical Company Information
Table 175. Zhejiang Huahai Pharmaceutical Introduction and Business Overview
Table 176. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Zhejiang Huahai Pharmaceutical Valsartan Drug Product
Table 178. Zhejiang Huahai Pharmaceutical Recent Development
Table 179. Square Pharmaceuticals Company Information
Table 180. Square Pharmaceuticals Introduction and Business Overview
Table 181. Square Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Square Pharmaceuticals Valsartan Drug Product
Table 183. Square Pharmaceuticals Recent Development
Table 184. Unichem Laboratories Company Information
Table 185. Unichem Laboratories Introduction and Business Overview
Table 186. Unichem Laboratories Valsartan Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Unichem Laboratories Valsartan Drug Product
Table 188. Unichem Laboratories Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Valsartan Drug Market Trends
Table 192. Valsartan Drug Market Drivers
Table 193. Valsartan Drug Market Challenges
Table 194. Valsartan Drug Market Restraints
Table 195. Valsartan Drug Distributors List
Table 196. Valsartan Drug Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Drug Product Picture
Figure 2. Global Valsartan Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Valsartan Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Valsartan Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 40 mg Tablets
Figure 6. Global 40 mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 80 mg Tablets
Figure 8. Global 80 mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 160 mg Tablets
Figure 10. Global 160 mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of 320 mg Tablets
Figure 12. Global 320 mg Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Valsartan Drug Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Valsartan Drug Sales Market Share by Type in 2022 & 2029
Figure 15. North America Valsartan Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Valsartan Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Valsartan Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Valsartan Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Valsartan Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Valsartan Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Valsartan Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Valsartan Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Valsartan Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Valsartan Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Valsartan Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Valsartan Drug Revenue in 2022
Figure 27. Valsartan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hypertension
Figure 29. Global Hypertension Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Heart Failure
Figure 31. Global Heart Failure Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Heart Attack
Figure 33. Global Heart Attack Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Valsartan Drug Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Valsartan Drug Sales Market Share by Application in 2022 & 2029
Figure 36. North America Valsartan Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Valsartan Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Valsartan Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Valsartan Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Valsartan Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Valsartan Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Valsartan Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Valsartan Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Valsartan Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Valsartan Drug Manufacturing Cost Structure
Figure 47. Valsartan Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries